# MAGNOSECT Biomedical Graphene Research - Grant Package

## Overview
**Division**: Biomedical Graphene Research  
**Technology**: MAGNOSECT Neuroshielding  
**Total Target**: $700K  
**Focus**: Graphene nanoparticle targeted delivery systems  

## NIH Grants Package

### Grant 1: NIH R01 - Neurological Protection
- **Amount**: $450,000
- **Deadline**: June 15, 2025
- **Match Score**: 90%
- **Focus**: Graphene nanoparticle delivery systems
- **Innovation**: Targeted neurological protection therapy

### Grant 2: NIH STTR - Clinical Applications
- **Amount**: $250,000
- **Deadline**: August 30, 2025
- **Match Score**: 88%
- **Focus**: Clinical translation of neuroshielding technology
- **Pathway**: FDA approval preparation

## Private Foundation Grants

### Bill & Melinda Gates Foundation
- **Amount**: $300,000
- **Focus**: Global health applications
- **Target**: Neurological protection in developing countries
- **Status**: Letter of Intent prepared

### Robert Wood Johnson Foundation
- **Amount**: $200,000
- **Focus**: Health innovation and equity
- **Application**: Community health neurological protection
- **Status**: Full proposal ready

## Technology Applications
- **First Responder Protection**: Neural damage prevention
- **Medical Treatment**: Targeted drug delivery
- **Community Health**: Preventive neurological care
- **Military Applications**: Combat-related brain injury prevention

## Clinical Development
- **Phase I Trials**: Safety and dosage determination
- **Phase II Trials**: Efficacy validation
- **FDA Pathway**: Medical device classification
- **Commercial Timeline**: 3-5 years to market

## Intellectual Property
- **Patent Portfolio**: 12 provisional patents filed
- **Trade Secrets**: Graphene synthesis methodology
- **Licensing Potential**: Multiple pharmaceutical partnerships

**Readiness Level**: 6/10 - Laboratory validation with animal testing initiated